Elite Pharmaceuticals Stock Dips Despite Record FY25 Revenue Jump
Shares of Elite Pharmaceuticals, Inc. ELTP have lost 15.7% since the company reported its earnings for the fiscal year ended March 31, 2025. This compares to the S&P 500 Index’s 0.9% gain over the same time frame. Over the past month, however, the stock rebounded …